Testing effectiveness (Phase 2)Active Not RecruitingNCT05180799What this trial is testingBA3071 in Patients With Solid TumorsWho this might be right forNSCLCMelanoma BioAtla, Inc. 320
Early research (Phase 1)Active Not RecruitingNCT03816332What this trial is testingTacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic CancersWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+18 more National Cancer Institute (NCI) 12
Not applicableActive Not RecruitingNCT04990726What this trial is testingImmune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint InhibitorsWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Pathologic Stage III Cutaneous Melanoma AJCC v8Pathologic Stage IIIA Cutaneous Melanoma AJCC v8+5 more M.D. Anderson Cancer Center 126
Testing effectiveness (Phase 2)UnknownNCT01676649What this trial is testingIpilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV MelanomaWho this might be right forUntreated Stage III Melanoma or Stage IV Melanoma Jewish General Hospital 30
Early research (Phase 1)Study completedNCT00390338What this trial is testingVaccine Therapy in Treating Patients With Stage III or Stage IV MelanomaWho this might be right forMelanoma (Skin) Pawel Kalinski 22
Early research (Phase 1)WithdrawnNCT00006126What this trial is testingPeripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With SurgeryWho this might be right forBreast CancerKidney CancerLung Cancer+2 more Northwestern University
Not applicableStudy completedNCT03553329What this trial is testingStudy of the Variations of Albumin Level for Patients With Unresecable Stage IIIc or Stage IV Melanoma Treated by Anti BRAF and Anti MEKWho this might be right forUnresecable Stage IIIc or IV Melanoma Poitiers University Hospital 20
Early research (Phase 1)UnknownNCT03353402What this trial is testingFecal Microbiota Transplantation (FMT) in Metastatic Melanoma Patients Who Failed ImmunotherapyWho this might be right forMelanoma Stage IvUnresectable Stage III Melanoma Sheba Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT00436605What this trial is testingDasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV MelanomaWho this might be right forRecurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+2 more National Cancer Institute (NCI) 39
Early research (Phase 1)UnknownNCT00037037What this trial is testingVaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic MelanomaWho this might be right forMelanoma (Skin) Herbert Irving Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT03980314What this trial is testingCompare Nivolumab Drug Product Process D to Nivolumab Drug Product Process C in Participants With Stage IIIa/b/c/d or Stage IV Melanoma After Complete ResectionWho this might be right forMelanoma Bristol-Myers Squibb 261
Large-scale testing (Phase 3)UnknownNCT00002767What this trial is testingInterferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) GlaxoSmithKline 300
Large-scale testing (Phase 3)Active Not RecruitingNCT05608291What this trial is testingA Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With SurgeryWho this might be right forMelanoma Regeneron Pharmaceuticals 1,564
Testing effectiveness (Phase 2)Study completedNCT00281541What this trial is testingThe Treatment of Unresectable Stage III or Metastatic Stage IV MelanomaWho this might be right forMelanoma Astellas Pharma Inc 29
Large-scale testing (Phase 3)UnknownNCT05647954What this trial is testingHX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the LiverWho this might be right forMelanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms Taizhou Hanzhong biomedical co. LTD 350
Testing effectiveness (Phase 2)Study completedNCT00110994What this trial is testingTreatment for Subjects With Unresectable Stage III or Stage IV MelanomaWho this might be right forCancerMelanoma Bayer 101
Testing effectiveness (Phase 2)Active Not RecruitingNCT04139902What this trial is testingNeoadjuvant PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor Cobolimab (TSR-022) and PD-1 Inhibitor Dostarlimab (TSR-042) in MelanomaWho this might be right forMelanoma Stage IIIMelanoma Stage IV Diwakar Davar 48
Large-scale testing (Phase 3)Study completedNCT00094653What this trial is testingMDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic MelanomaWho this might be right forMelanomaMetastases Bristol-Myers Squibb 1,783
Early research (Phase 1)Ended earlyNCT02419495What this trial is testingPhase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesWho this might be right forAdvanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more M.D. Anderson Cancer Center 221
Testing effectiveness (Phase 2)Study completedNCT00610857What this trial is testingSafety and Efficacy of Combination HDI and Anti-CTLA4 for Recurrent Inoperable Stage III or Stage IV MelanomaWho this might be right forMelanoma Ahmad Tarhini 37